Ranexa Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Ranexa 375 mg prolonged-release tablets: Each tablet contains 375 mg of ranolazine.
Ranexa 500 mg prolonged-release tablets: Each tablet contains 500 mg of ranolazine.
Ranexa 750 mg prolonged-release tablets: Each tablet contains 750 mg of ranolazine.
Excipients/Inactive Ingredients: Each tablet contains 0.04 mg azo colouring agent E102 and 12.0 mg lactose monohydrate.
Excipients for all ranolazine prolonged-release tablets: Carnauba wax, Hypromellose, Magnesium stearate, Methacrylic acid-ethyl acrylate copolymer (1:1), Microcrystalline cellulose, Sodium hydroxide, Titanium dioxide.
Additional excipients for 375 mg tablet: Macrogol, Polysorbate 80, Blue #2/Indigo Carmine Aluminum Lake (E1332).
Additional excipients for 500 mg tablet: Macrogol, Polyvinyl alcohol hydrolyzed Iron oxide yellow (E172), Iron oxide red (E172), Iron oxide red (E172), Talc.
Additional excipients for 750 mg tablet: Glycerol triacetate, Lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminum Lake (E133) and Yellow #5/Tartrazine, Aluminum Lake (E102).

ranolazine

Manufacturer:

A. Menarini

Distributor:

Zuellig Pharma